Medtronic (MDT) Outperforms Broader Market: What You Need to Know

On the latest trading day, Medtronic (MDT) closed at $90.07, marking a positive change of +0.92% from the previous day's close. This performance is notable as it outstripped the S&P 500, which saw an increase of 0.41%. In comparison, the Dow Jones also rose by 0.69%, while the Nasdaq, heavily tilted towards technology, experienced a gain of 0.8%.

Over the past month, Medtronic's stock has appreciated by 1.69%. This contrasts sharply with the Medical sector, which has faced a decline of 4.61%, and the broader S&P 500, which has dropped by 0.97% during the same period.

Investors and analysts are keenly awaiting Medtronic's upcoming earnings report. The consensus expectations suggest the company will report earnings per share (EPS) of $1.24, reflecting a decline of 0.8% compared to the same quarter last year. Additionally, projected revenue stands at $8.26 billion, representing a 3.47% increase from the previous year’s corresponding quarter.

For the entire fiscal year, the Zacks Consensus Estimates forecast that Medtronic will achieve earnings of $5.44 per share and total revenue of $33.6 billion – changes of +4.62% and +3.81% respectively compared to the previous year.

It is important for investors to take note of the recent updates in analyst estimates for Medtronic. Changes in estimates usually reflect current business trends, with upward adjustments indicating positive sentiment among analysts regarding the company's financial performance.

Research highlights a strong correlation between revisions in estimates and stock price movements. To leverage this, a proprietary model known as the Zacks Rank is utilized to evaluate these estimate changes, providing a comprehensive rating system.

The Zacks Rank ranges from #1 (Strong Buy) to #5 (Strong Sell) and has demonstrated a strong historical performance; since 1988, #1 ranked stocks have delivered an average annual gain of +25%. Over the last month, the consensus EPS estimate has decreased by 0.33%, positioning Medtronic currently at a Zacks Rank of #3 (Hold).

Valuation is crucial for investors to consider as well. Medtronic's Forward P/E ratio stands at 16.42, which is favorable when compared to its industry average Forward P/E of 22.79, suggesting that Medtronic shares are trading at a discount relative to its peers.

Furthermore, MDT bears a PEG ratio of 2.55. This ratio, similar to the P/E ratio, accounts for the expected earnings growth rate. In comparison, the Medical - Products industry averages a PEG ratio of 1.87 as of the last closing.

Medtronic is part of the Medical - Products industry, which itself is included in the Medical sector. The sector has a Zacks Industry Rank of 68, placing it in the top 27% of over 250 industries. Zacks Industry Ranks are determined by the average Zacks Rank of the companies in each industry and demonstrate that higher-ranked industries tend to outperform lower-ranked ones by a factor of 2 to 1.

Investors are advised to continue monitoring these indicators and stock-influencing metrics as trading sessions unfold.

Medtronic, stock, market